Implanet receives clearance for total knee prosthesis — 3 things to know

The FDA granted Implanet a 510(k) clearance for the cemented version of its Madison total knee prosthesis.

Advertisement

Three things to know:

1. Seven years of clinical results and data as well as 17,000 implants supported the decision.

2. The implant features cobalt chrome femoral and tibial components.

3. Implanet employs 38 staff and recorded $6.7 million in sales in 2018.

More articles on devices:
Orthofix reports $40.5M net loss in Q3, Jon Serbousek to become CEO: 5 details
New York orthopedic center to introduce robot for total knee replacements

California court tosses portion of labor suit against Zimmer Biomet — 4 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.